Rossmax International Ltd. Visits Valencell’s HQ in Raleigh to Explore Fingertip™ BPM Market Opportunities
May 25, 2023
Mr. Liu, President & CEO of Rossmax International Ltd., and the Rossmax team visited Valencell’s headquarters in Raleigh, NC to discuss how to expand their relationship around the Fingertip™ Blood Pressure Monitor – the world’s first OTC blood pressure monitor at the fingertip that is cuffless and calibration-free; not FDA cleared and not for sale in the US.
“We are excited to work with Rossmax to further explore market opportunities for our Fingertip™ Blood Pressure Monitor technology.” Kent Novak, CEO of Valencell said. “Both of our companies have a long history of pioneering research and product development, as well as a shared commitment to supplying premium products with supreme technologies.”
Rossmax, established in 1988 and headquartered in Taipei, Taiwan, engages in the design, sale, manufacture, research, and development of healthcare products. They operate through the fields of Prevention, Monitoring, and Therapy including personal scales for fitness and obesity measurement, blood pressure monitoring devices for hypertension, nebulizers for inhalation, digital thermometers for fever monitoring, and heating wraps for pain relief and therapy solutions. Rossmax distributes their healthcare products through their drugstore chain in Taiwan, and in over 90 countries worldwide.
Valencell is an acclaimed innovator of intuitive, accurate and easy to incorporate digital health solutions with a focus on addressing unmet needs in the prevention and management of chronic diseases like hypertension. Ourproprietary biometric sensor technology, algorithms and machine learning analytics are protected by 150+ awarded patents, and power tens of millions of devices worldwide. Founded in 2006 and headquartered in Raleigh, NC, Valencell’s mission is to empower people to live longer, healthier lives.